Citation Impact
Citing Papers
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
2014 Standout
Molecular Heterogeneity and Receptor Coamplification Drive Resistance to Targeted Therapy in MET -Amplified Esophagogastric Cancer
2015
E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group
2017
The Opposing Function of STAT3 as an Oncoprotein and Tumor Suppressor Is Dictated by the Expression Status of STAT3β in Esophageal Squamous Cell Carcinoma
2015
Head and neck squamous cell carcinoma
2020 Standout
A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma
2015
Head and neck cancers—major changes in the American Joint Committee on cancer eighth edition cancer staging manual
2017 Standout
Germline development from human pluripotent stem cells toward disease modeling of infertility
2012 StandoutNobel
QuPath: Open source software for digital pathology image analysis
2017 Standout
Enhanced expression of Annexin A4 in clear cell carcinoma of the ovary and its association with chemoresistance to carboplatin
2009
Persistent endocrine-disrupting chemicals found in human follicular fluid stimulate the proliferation of granulosa tumor spheroids via GPR30 and IGF1R but not via the classic estrogen receptors
2018
Ovarian cancer
2014 Standout
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment
2016 Standout
Phosphorylation of signal transducer and activator of transcription 3 in soft tissue leiomyosarcoma is associated with a better prognosis
2012
Genetic changes in nonepithelial ovarian cancer
2013
Macrophages in immunoregulation and therapeutics
2023 Standout
The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours
2015
Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity
2011
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
The Role of Hepatocyte Nuclear Factor-1A in the Pathogenesis of Clear Cell Carcinoma of the Ovary
2009
Management Strategies for Recurrent Platinum-Resistant Ovarian Cancer
2011
Novel targets in HPV-negative head and neck cancer: overcoming resistance to EGFR inhibition
2013
Tetraarsenic oxide and cisplatin induce apoptotic synergism in cervical cancer
2013
miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells
2012
Beta-Catenin Accelerates Human Papilloma Virus Type-16 Mediated Cervical Carcinogenesis in Transgenic Mice
2011
Oxidative Stress in Cancer
2020 Standout
The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
2014 Standout
Tumour burden and efficacy of immune-checkpoint inhibitors
2021
Association of Five Snps in Cytotoxic T-Lymphocyte Antigen 4 and Cancer Susceptibility: Evidence from 67 Studies
2018
A metabolic labeling approach for glycoproteomic analysis reveals altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cells
2016 StandoutNobel
Cisplatin: The first metal based anticancer drug
2019 Standout
Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)
2017
CD39 and CD73 in immunity and inflammation
2013 Standout
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Recent progress in the diagnosis and treatment of ovarian cancer
2011
Digital pathology and image analysis in tissue biomarker research
2014
Endometriosis: pathogenesis and treatment
2013 Standout
Cervical cancer
2019 Standout
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Tumour heterogeneity and resistance to cancer therapies
2017 Standout
Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors
2018 StandoutNobel
Head and Neck Cancer
2020 Standout
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
The Therapeutic Potential of Apigenin
2019 Standout
Ovarian cancer statistics, 2018
2018 Standout
Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage
2018
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research
2020 Standout
Mitogen-activated protein kinase signaling pathway in oral cancer (Review)
2017
STAT3 and STAT5 Activation in Solid Cancers
2019
p16 status, pathologic and clinical characteristics, biomolecular signature, and long‐term outcomes in head and neck squamous cell carcinomas of unknown primary
2013
Emerging Insights into Wnt/β-catenin Signaling in Head and Neck Cancer
2018
The Mammalian Ovary from Genesis to Revelation
2009
Prognostic role of epidermal growth factor receptor in head and neck cancer: A meta-analysis
2013
Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505
2015
Works of Eirini Pectasides being referenced
Nuclear Localization of Signal Transducer and Activator of Transcription 3 in Head and Neck Squamous Cell Carcinoma Is Associated with a Better Prognosis
2010
Activation of Wnt Signaling Pathway by Human Papillomavirus E6 and E7 Oncogenes in HPV16-Positive Oropharyngeal Squamous Carcinoma Cells
2010
Prognostic Biomarkers in Phase II Trial of Cetuximab-Containing Induction and Chemoradiation in Resectable HNSCC: Eastern Cooperative Oncology Group E2303
2014
Quantitative assessment shows loss of antigenic epitopes as a function of pre-analytic variables
2011
Preexisting oncogenic events impact trastuzumab sensitivity in ERBB2-amplified gastroesophageal adenocarcinoma
2014
Carboplatin/gemcitabine alternating with carboplatin/pegylated liposomal doxorubicin and carboplatin/cyclophosphamide in platinum-refractory/resistant paclitaxel — pretreated ovarian carcinoma
2010
Markers of Epithelial to Mesenchymal Transition in Association with Survival in Head and Neck Squamous Cell Carcinoma (HNSCC)
2014
Chemotherapy for recurrent cervical cancer
2008
Nuclear epidermal growth factor receptor and p16 expression in head and neck squamous cell carcinoma
2012
Carboplatin and Paclitaxel in Metastatic or Recurrent Cervical Cancer
2009
Evaluation of six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon therapy in the He13A/98 multicenter trial
2010
Maintenance or Consolidation Therapy in Advanced Ovarian Cancer
2006
Germ cell tumors of the ovary
2008
Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303)
2014
Adult granulosa cell tumors of the ovary: a clinicopathological study of 34 patients by the Hellenic Cooperative Oncology Group (HeCOG).
2008
Correlates and Determinants of Nuclear Epidermal Growth Factor Receptor Content in an Oropharyngeal Cancer Tissue Microarray
2008
Sequencing Treatment in BRAF V600 Mutant Melanoma: Anti-PD-1 Before and After BRAF Inhibition
2016
Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions
2020
Treatment Issues in Clear Cell Carcinoma of the Ovary: A Different Entity?
2006
Comparative Prognostic Value of Epidermal Growth Factor Quantitative Protein Expression Compared with FISH for Head and Neck Squamous Cell Carcinoma
2011